Healthline5d
Why Super Bowl Champ Dallas Goedert Is Raising Awareness About Plaque Psoriasis
Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...
The American Journal of Managed Care7d
Oral Roflumilast Shows Promise for Moderate to Severe Psoriasis
Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.
How Do You Know It’s Psoriasis? Here Are The Signs And Symptoms You Should Look For
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Healio27d
AX-158 impacts biomarkers in patients with mild, moderate plaque psoriasis
AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque psoriasis, Artax Biopharma announced in a press release.
Healio5h
Connection between skin disease, heart health ushers in ‘holistic’ era of dermatology
In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...
pharmaphorum2d
Amgen builds Otezla's psoriasis label as rival BMS looms large
The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...
The American Journal of Managed Care7d
Bimekizumab for Hidradenitis Suppurativa Offers Durable Disease Control in Long-Term Data
New 2-year data show the long-term effects of bimekizumab on hidradenitis suppurativa, indicating its potential as a valuable ...
The Daily Telegraph23d
‘Not unsafe’: NSW vows to expand script-free treatment
Eligible patients with shingles, eczema, school sores and “mild plaque psoriasis” have received treatment without requiring a prescription from their doctor. The move to utilise pharmacists is ...